Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
56 hedge funds and large institutions have $185M invested in Alimera Sciences in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 6 closing their positions.
200% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 6
143% more capital invested
Capital invested by funds: $76M → $185M (+$109M)
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
27% more funds holding
Funds holding: 44 → 56 (+12)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
48% less call options, than puts
Call options by funds: $837K | Put options by funds: $1.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$9.71M |
| 2 |
O
OrbiMed
New York
|
+$9.71M |
| 3 |
DM
Deerfield Management
New York
|
+$8.49M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$4.32M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$2.76M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$183K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$162K |
| 4 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$115K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $5K | +$2.43K | +25 | +100% |
|
52
BNP Paribas Financial Markets
Paris,
France
| $4.46K | +$486 | +5 | +11% |
|
53
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
54
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
55
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $116 | +$88.9K | +915 | +1,452% |
|
|
VKH
56
Virtu KCG Holdings
New York
| – | -$183K | -2,594 | Closed |
|
|
NFA
57
Nationwide Fund Advisors
Columbus,
Ohio
| – | -$64K | -903 | Closed |
|
|
U
58
UBS
Zurich,
Switzerland
| – | -$25.6K | -264 | Closed |
|
|
S
59
SignatureFD
Atlanta,
Georgia
| – | -$14K | -196 | Closed |
|
60
Wells Fargo
San Francisco,
California
| – | -$12.8K | -132 | -99% |
|
|
HTC
61
Hershey Trust Company
Hershey,
Pennsylvania
| – | -$5K | -75 | Closed |
|
62
AllianceBernstein
Nashville,
Tennessee
| – | -$3K | -47 | Closed |
|
ALIM Hedge Fund Activity: Q1 2014 in Review
56 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2014, worth a combined $185M — up 143% from $76M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ALIM positions and 6 closed out — a net gain of 12 holders — while 18 added to existing stakes and 13 trimmed.
The largest buyer was Great Point Partners, opening a new position worth an estimated $9.71M. The largest seller was NEA Management Company, cutting an estimated $2.76M.
- 56 institutional investors held Alimera Sciences (ALIM) as of Q1 2014, up from 44 in Q4 2013.
- Funds reported $185M of Alimera Sciences stock for Q1 2014, up 143% quarter-over-quarter.
- 18 funds opened new Alimera Sciences positions in Q1 2014 and 6 closed out, a net change of +12 holders.
- The largest Alimera Sciences buyer in Q1 2014 was Great Point Partners, an estimated $9.71M added.
- The largest Alimera Sciences seller in Q1 2014 was NEA Management Company, an estimated $2.76M sold.
Based on aggregated 13F filings for Q1 2014.